Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis - Palmer, Suetonia C; Mavridis, Dimitris; Navarese, Eliano; Craig, Jonathan C; Tonelli, Marcello; Salanti, Georgia; Wiebe, Natasha; Ruospo, Marinella; Wheeler, David C; Strippoli, Giovanni F M (The Lancet (British edition), 2015)
Keywords: ACE inhibitors; Angiotensin Receptor Antagonists - therapeutic use; Angiotensin-Converting Enzyme Inhibitors - therapeutic use; Antihypertensive Agents - therapeutic use; Blood pressure; Diabetes; Diabetes Mellitus, Type 1 - complications; Diabetes Mellitus, Type 1 - mortality; Diabetes Mellitus, Type 1 - prevention & control; Diabetes Mellitus, Type 2 - complications; Diabetes Mellitus, Type 2 - mortality; Diabetes Mellitus, Type 2 - prevention & control; Diabetic Angiopathies - complications; Diabetic Angiopathies - drug therapy; Diabetic Nephropathies - complications; Diabetic Nephropathies - mortality; Diabetic Nephropathies - prevention & control; Diuretics; Heart attacks; Humans; Hypertension; Hypertension - complications; Hypertension - drug therapy; Hypertension - mortality; Internal Medicine; Kidney diseases; Kidney Failure, Chronic - complications; Kidney Failure, Chronic - mortality; Kidney Failure, Chronic - prevention & control; Kidneys; Medical research; Middle Aged; Mortality; Randomized Controlled Trials as Topic; Safety; Studies; Systematic review; Treatment Outcome